Analysis of digestive endoscopic results during COVID-19

Abstract

ObjectiveThis study aims to explore the necessity and safety of digestive endoscopy during the epidemic of coronavirus disease 2019.MethodsA retrospective cohort study method was used to collect patients’ data from the endoscopy center of the Civil Aviation General Hospital of China from February 1 to May 31, 2020, as the observation group. The patients’ data of endoscopic diagnosis and treatment during the same period in 2019 were used as a control group, to compare the differences in the number of diagnosis and treatment and the detection rate of gastrointestinal diseases in the two groups. At the same time, patients and related staff were followed up for the situation of new infection.ResultsDuring the epidemic, our endoscopy center conducted a total of 1,808 cases of endoscopic operations and 5,903 cases in the control group. The amount of endoscopic work during the epidemic period was 30.63% in the same period last year. During the epidemic, 26 patients underwent endoscopic mucosal resection (EMR)/endoscopic submucosal dissection (ESD) treatment, 26 patients underwent ERCP, and 18 patients underwent gastrointestinal stent implantation. In the control group, 273 patients underwent EMR/ESD, 17 underwent ERCP, and 16 underwent gastrointestinal stenting. During COVID-19, compared with the same period last year, the detection rates of peptic ulcer, esophageal cancer, gastric cancer, colon cancer, and rectal cancer were significantly higher (χ2 = 4.482, P = 0.034; χ2 = 5.223, P = 0.006; χ2 = 2.329, P = 0.041; χ2 = 8.755, P = 0.003; and χ2 = 5.136, P = 0.023). Through telephone follow-up, novel coronavirus nucleic acid detection and blood antibody detection, no patients or medical staff were infected with the novel coronavirus.ConclusionDuring COVID-19, the number of digestive endoscopic operations decreased significantly compared with the same period last year, but the detection rate of various diseases of the digestive tract increased significantly. On the basis of strict prevention and control, orderly recovery of endoscopic work is essential.

The Impact of the COVID-19 Epidemic on Diagnosis, Treatment, Concerns, Problems, and Mental Health in Patients with Gastric Cancer

“…There is a linear model relationship between the number of endoscopies and gastric cancer [ 18 ]. The number of endoscopies decreased during the COVID-19 epidemic, but the rate of diagnosis increased significantly [ 16 ].…”

“…During corona virus limitations, the diagnosis of cancer has been significantly reduced. But after lifting the restrictions, the endoscopy performance returned to normal The endoscopies were postponed or canceled Lui [ 18 ] China A population-based study Good The average number of stomach cancers diagnosed each week decreased by 46.2% The results of linear regression model showed that there is a relationship between the number of gastric cancers and endoscopy performing Huang [ 16 ] China A retrospective cohort study Good Endoscopy decreased by 30.63% during the epidemic compared to the same period last year. The rate of gastric cancer diagnosed has increased in endoscopies Armellini [ 28 ] Italy Retrospectively analyzed endoscopies Good In the study of 847 patients from 13 centers in Italy for endoscopy.…”

“…Lack of personal protective equipment such as masks, gowns, and gloves; lack of hospital staff due to illness; quarantine; lack of hospital and ICU beds; and social distance observing were the reasons for quotas and triage for the treatment of patients by oncologist [ 30 ]. Changes in the treatment of patients depend on the severity of the epidemic and risk factors in patients such as age over 75 years, comorbidities including hypertension, diabetes, liver failure, kidney, and lung failure [ 16 ]. The effects of COVID-19 epidemic on the treatment and follow-up of gastric cancer are summarized in Table 2 .…”

“…Although the number of endoscopies has decreased, the incidence of gastric cancer has increased significantly. In other words, the rate of gastric cancer diagnosed has increased in endoscopies [ 16 ]. The effects of the COVID-19 epidemic on gastric cancer include therapeutic changes modification, delay, or discontinuation of treatment.…”

“…A total of 22 studies were eligible for the study according to the objectives of the study and were divided into four categories. The effect of COVID-19 epidemic on the diagnosis of gastric cancer [2,4,5,[15][16][17][18][19], treatment and follow-up [1,[20][21][22][23], problems and concerns of patients with gastric cancer [20,21,24,25], and health psychiatry of patients with gastric cancer [1,25,26].…”